HERCULES PHARMACEUTICALS
Hercules is a biopharmaceutical company developing an innovative, oral, non-toxic drug therapy for chronic treatment of patients with Triple Negative Breast Cancer, and other solid tumors. The company has demonstrated that blocking the Aryl hydrocarbon Receptor in solid tumors could: Enhance the response of the immune system to cancer Reduce the chance of future relapses by reducing the number of Cancer Stem Cells Reduce metastatic behavior Reduce agression of existing cancer Make cancer cells more sensitive to standard chemotherapy Hercules have discovered novel anti-cancer drugs that block the Aryl Hydrocarbon receptor and is now testing these products in preparation for clinical trials.
HERCULES PHARMACEUTICALS
Industry:
Biopharma Biotechnology Clinical Trials
Founded:
2013-01-01
Address:
Leiden, Zuid-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.hercules-pharma.nl
Total Employee:
11+
Status:
Active
Contact:
+31 (0)346745139
Email Addresses:
[email protected]
Total Funding:
300 K EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Euro
Current Employees Featured
Founder
Investors List
UNIIQ
UNIIQ investment in Seed Round - Hercules Pharmaceuticals
Official Site Inspections
http://www.hercules-pharma.nl
- Host name: shared3.inforitus.nl
- IP address: 213.132.223.120
- Location: Netherlands
- Latitude: 52.3824
- Longitude: 4.8995
- Timezone: Europe/Amsterdam